Innovations in Clinical Research Award

Print Share
 

Innovations in Clinical Research Award

Purpose

The Doris Duke Innovations in Clinical Research Award provides funding for early-stage research projects in clinical investigation to foster innovations in clinical research that advance the prevention, diagnosis and treatment of human disease.

Rationale & Program History

The Medical Research Program created the Innovations in Clinical Research Award (ICRA) to promote collaborations and catalyze breakthroughs in targeted disease areas. We believe that the potential of scientific discoveries to spur field-changing advances increases when new multidisciplinary perspectives are brought into the problem-solving process.

Since 2000, 66 awards totaling approximately $21 million have supported innovative clinical research in cardiovascular disease, stroke, blood disorders, sickle cell disease, and the development of diagnostics and therapeutic monitoring of AIDS in resource-poor countries.    

Award Details

The Innovations in Clinical Research Award provides three-year grants of $486,000 each to investigators conducting clinical research that has the potential to accelerate innovative breakthroughs in sickle cell disease. View the 2013 grantees here. 

New grants are not being offered at this time. 
To be notified of future funding opportunities, sign up for the Medical Research Program's mailing list.